Jiří Kolář

Cystic Appearance on Imaging Methods (Bosniak III-IV) in Histologically Confirmed Papillary Renal Cell Carcinoma is Mainly Characteristic of Papillary Renal Cell Carcinoma Type 1 and Might Predict a Relatively Indolent Behavior of Papillary Renal Cell Carcinoma

M. Staehler, O. Hes, J. Ferda, 2018, Urologia Internationalis.

Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate

J. Filipovský, O. Fiala, S. Buti, 2024, Cancer medicine.

Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study.

E. Compérat, A. Osunkoya, M. Tretiakova, 2022, Annals of diagnostic pathology.

Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.

A. Osunkoya, M. Tretiakova, R. Alaghehbandan, 2019, Annals of diagnostic pathology.

Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience

O. Topolcan, O. Fiala, J. Windrichova, 2022, AntiCancer Research.